Logo-jcvtr
Submitted: 25 Sep 2019
Accepted: 11 Jan 2020
ePublished: 28 Jan 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2020;12(1): 10-14.
doi: 10.34172/jcvtr.2020.02
PMID: 32211132
PMCID: PMC7080333
  Abstract View: 189
  PDF Download: 143

Original Article

Novel single nucleotide mutations in exon-10 of human coagulation Factor V gene in patients with pulmonary thromboembolism

Latheef Kasala 1 * ORCID logo, Rajasekhar Durgaprasad 1, Vanajakshamma Velam 1

1 Department of Cardiology, Sri Venkateswara Institute of Medical Sciences & University, Tirupati, Andhra Pradesh, India
*Corresponding Author: Latheef Kasala, Email: klf.svims@gmail.com

Abstract

Introduction: Acute pulmonary thromboembolism (PTE) presents with wide spectrum and has variable prognosis. Factor V Leiden (FVL) is the most common inherited thrombophilia, with a prevalence of 3%-7% in the general US population, approximately 5% in Whites, 2.2% in Hispanics and 1.2% in Blacks. PTE most commonly originates from venous thrombosis. The occurrence of venous thromboembolism is a culmination of environmental and genetic risk factors. The current study was sought to identify the mutations in exon-10 of FV gene in patients with PTE.
Methods: Sixty cases diagnosed with PTE and 50 healthy controls were enrolled in the present study. Mutation studies in exon-10 of Factor V gene included PCR-DNA sequencing method.
Results: Of 60 patients, we found two novel transition type point mutations: c.1538 G>A and c.1601 G>A in exon-10 of Factor V which is responsible for the cleavage site for aPC. These point mutations resulted in single amino acid change in protein sequence at p.Arg513Lys and p.Arg534Gln respectively. These mutations prevent efficient inactivation of Factor V and Factor V remains active which facilitates over production of thrombin leading to generation of excess fibrin and excess coagulation which results in deep vein thrombosis and PTE.
Conclusion: We report two novel point mutations (c.1538 G>A and c.1601 G>A) in exon-10 of Factor V gene in Indian patients with PTE.
Keywords: Pulmonary Thromboembolism, Factor V, Mutations
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 189

Your browser does not support the canvas element.


PDF Download: 143

Your browser does not support the canvas element.